SCHEMBL7659961

SCHEMBL7659961

CCCCC(NC(=O)c1ccc(NC(=O)c2ccc3ccccc3c2)cc1)C(=O)CNC(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
CCKBR P32239 1/20 0.52
CASP1 P29466 2/20 0.50
NR1H4 Q96RI1 1/20 0.48
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
CASP3 P42574 2/20 0.47
SENP7 Q9BQF6 2/20 0.47
DEGS1 O15121 1/20 0.47
PLAU P00749 2/20 0.46
KDM4E B2RXH2 2/20 0.45
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
POLB P06746 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP6 Q9GZR1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7668656 0.92 KMT2A (0.52) MEN1KMT2ACCKBRCASP1NR1H4
SCHEMBL7668106 0.91 CASP1 (0.46) MEN1KMT2ACCKBRCASP1NR1H4
SCHEMBL7665000 0.84 ALDH1A1 (0.52) MEN1KMT2ACCKBRPLAUSMN1; SMN2
SCHEMBL7659998 0.82 MEN1 (0.45) MEN1KMT2ACCKBRCASP1NPC1
SCHEMBL7664997 0.82 PTPN1 (0.51) MEN1KMT2ACCKBRNPC1RAB9A
SCHEMBL7661370 0.81 CCKBR (0.44) MEN1KMT2ACCKBRCASP1KDM4E
SCHEMBL7659849 0.81 AKR1C3 (0.47) MEN1KMT2ACCKBRPLAUSMN1; SMN2
SCHEMBL7654043 0.77 ALDH1A1 (0.54) KMT2ACCKBRPLAUSMN1; SMN2HDAC3
SCHEMBL7697322 0.77 CAPN1 (0.54) CCKBRCASP1
SCHEMBL7428036 0.76 CA2 (0.45) CCKBRNPC1RAB9ASMN1; SMN2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed